MacroGenics, Inc.
MGNX
$4.11
-$0.21-4.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 377.97% | -4.56% | 113.03% | -34.21% | -36.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 377.97% | -4.56% | 113.03% | -34.21% | -36.38% |
| Cost of Revenue | -4.93% | -11.90% | -0.66% | 4.44% | -25.23% |
| Gross Profit | 82.47% | 13.48% | 88.56% | -58.21% | 22.48% |
| SG&A Expenses | -15.03% | -9.40% | -66.79% | -29.77% | -35.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.81% | -11.37% | -26.13% | -4.09% | -27.38% |
| Operating Income | 67.95% | 12.48% | 77.11% | -65.61% | 25.71% |
| Income Before Tax | -63.43% | 1.17% | -3.14% | -70.13% | 23.45% |
| Income Tax Expenses | -- | -- | -182.31% | -- | -- |
| Earnings from Continuing Operations | -63.03% | 1.17% | 8.21% | -70.13% | 23.26% |
| Earnings from Discontinued Operations | 1,278.86% | 502.40% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 153.83% | 10.39% | 8.21% | -70.13% | 34.88% |
| EBIT | 67.95% | 12.48% | 77.11% | -65.61% | 25.71% |
| EBITDA | 68.19% | 12.80% | 79.54% | -63.54% | 26.70% |
| EPS Basic | 153.45% | 11.06% | 8.92% | -70.36% | 35.36% |
| Normalized Basic EPS | 60.67% | 1.93% | 70.79% | -70.35% | 24.03% |
| EPS Diluted | 152.59% | 11.93% | 10.30% | -70.36% | 35.36% |
| Normalized Diluted EPS | 60.67% | 1.93% | 70.79% | -70.33% | 24.03% |
| Average Basic Shares Outstanding | 0.73% | 0.77% | 0.79% | 0.78% | 0.75% |
| Average Diluted Shares Outstanding | 0.73% | 0.77% | 0.79% | 0.66% | 0.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |